Drugs / Yiqilishui formula
Yiqilishui formula
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06686355 | Nov 2024 → Dec 2026 expected | myocardial disorder | Dongzhimen Hospital, Beijing | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yiqilishui formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06686355 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese medicine - Yiqilishui formula” NCT06686355 ↗ |
| Route | Oral | “oral or nasogastric administration of a granule preparation of Yiqilishui formula” NCT06686355 ↗ |